Neuberger Berman Group
ROIV icon

Neuberger Berman Group’s Roivant Sciences ROIV Stock Holding History

Neuberger Berman Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
45,291
+621
+1% +$18.4K ﹤0.01% 1368
2026
Q1 		$1.24M Sell
44,670
-175
-0.4% -$4.5K ﹤0.01% 1333
2025
Q4 		$973K Buy
44,845
+1,088
+2% +$21.5K ﹤0.01% 1403
2025
Q3 		$662K Buy
43,757
+52
+0.1% +$644 ﹤0.01% 1509
2025
Q2 		$493K Buy
43,705
+24,508
+128% +$266K ﹤0.01% 1576
2025
Q1 		$194K Sell
19,197
-21,000
-52% -$227K ﹤0.01% 1821
2024
Q4 		$476K Sell
40,197
-323
-0.8% -$3.82K ﹤0.01% 1536
2024
Q3 		$468K Buy
40,520
+21,497
+113% +$245K ﹤0.01% 1544
2024
Q2 		$201K Buy
19,023
+408
+2% +$4.47K ﹤0.01% 1765
2024
Q1 		$196K Sell
18,615
-17,599
-49% -$190K ﹤0.01% 1744
2023
Q4 		$407K Buy
+36,214
New +$353K ﹤0.01% 1756

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Neuberger Berman Group's ROIV Position: Q2 2026 in Review

Neuberger Berman Group increased its Roivant Sciences (ROIV) stake by 1.4% in Q2 2026, buying an estimated $18.4K and bringing the position to 45,291 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

Neuberger Berman Group first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Neuberger Berman Group held 45,291 shares of Roivant Sciences worth $1.6M as of Q2 2026.
  • Neuberger Berman Group bought 621 Roivant Sciences shares in Q2 2026, an estimated $18.4K.
  • Roivant Sciences made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1368 holding.
  • Neuberger Berman Group first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.